Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARDIDEN LTD Share Issue/Capital Change 2018

Feb 14, 2018

64307_rns_2018-02-14_f01b9ce9-6be6-44b1-8665-d115b4035012.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

==> picture [150 x 102] intentionally omitted <==

15 February 2018

ARDIDEN LIMITED

CLEANSING STATEMENT

Ardiden Limited (ASX: ADV – the “Company” or “Ardiden”) has issued and allotted 1,937,500 ordinary shares as part of a related party placement and issued 387,500 unlisted options and allotted 325,000 ordinary shares upon conversion of these unlisted options. Below is the applicable Cleansing Notice.

Secondary Trading Exemption:

The Act restricts the on-sale of securities issued without disclosure, unless the sale is exempt under Section 708 or 708A. By the Company giving this notice, a sale of the Securities noted above will fall within the exemption in section 708A(5) of the Act.

The Company hereby notifies the ASX under paragraph 708(A)(5)(e) of the Act that:

  • a) The Company issued the Securities without disclosure to investors under Part 6D.2 of the Act;

  • b) As at the date of this notice the Company has complied with the provisions of Chapter 2M of the Act as they apply to the Company, and section 674 of the Act; and

  • c) As at the date of this notice there is no information:

  • i) that has been excluded from a continuous disclosure notice in accordance with the Listing Rules; and

  • ii) that investors and their professional advisors would reasonably require for the purpose of making an informed assessment of:

    • (1) The assets and liabilities, financial position and performance, profits and losses and prospects of the Company; or

    • (2) The rights and liabilities attaching to the Securities.

Yours sincerely

Jessamyn Lyons Company Secretary Ardiden Limited

Ardiden Limited Suite 12, 11 Ventnor Avenue West Perth WA 6005 Australia

Tel: +61 (0) 8 6245 2050 Fax: +61 (0) 8 6245 2050 [email protected]

www.ardiden.com.au

Appendix 3B New issue announcement

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12

Name of entity

Ardiden Ltd ABN 82 110 884 252

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1
+Class of+securities issued or to
be issued
2
Number of+securities issued or to
be issued (if known) or maximum
number which may be issued
3
Principal terms of the+securities
(eg, if options, exercise price and
expiry
date;
if
partly
paid
+securities, the amount outstanding
and due dates for payment; if
+convertible
securities,
the
conversion price and dates for
conversion)
1. Fully paid ordinary shares
2. Unlisted options
3. Fully paid ordinaryshares
1. 1,937,500 fully paid ordinary shares
2. 387,500 Unlisted options
3. 325,000 fully paid ordinary shares
1. Fully paid ordinary shares.
2. Unlisted options,
- Exercise price $0.016 cents,
- Expiry 29 November 2018.
3. Fully paid ordinary shares.
  • See chapter 19 for defined terms.

Appendix 3B Page 0

01/08/2012

Appendix 3B New issue announcement

4 Do the[+] securities rank equally in 1. Yes – fully paid ordinary shares. all respects from the date of 2. No, but upon conversion into ordinary allotment with an existing[+] class of shares, yes. quoted[+] securities? 3. Yes – fully paid ordinary shares. If the additional securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 5 Issue price or consideration 1. $0.016 per share

  1. $0.016 per share 2. nil 3. $0.016 per share

6 Purpose of the issue 1. Cash raised via placement to related (If issued as consideration for the parties is to fund ongoing resource acquisition of assets, clearly drilling and exploration programs at its identify those assets) flagship Seymour Lake Lithium Project in Ontario Canada and working capital requirements as approved by shareholders at the General Meeting held on 13 February 2018. 2. Issue of unlisted options attached to the placement shares above. 3. Cash raised via conversion of unlisted options is to fund ongoing resource drilling and exploration programs at its flagship Seymour Lake Lithium Project in Ontario Canada and working capital requirements.

6a Is the entity an[+] eligible entity that has obtained security holder approval under rule 7.1A?

Yes

If Yes, complete sections 6b – 6h in relation to the[+] securities the subject of this Appendix 3B , and comply with section 6i

6b The date the security holder 29 November 2017 resolution under rule 7.1A was passed

  • See chapter 19 for defined terms.

Appendix 3B Page 1

01/08/2012

Appendix 3B New issue announcement

6c
Number
of
+securities
issued
without security holder approval
under rule 7.1
6d
Number of+securities issued with
security holder approval under rule
7.1A
6e
Number of+securities issued with
security holder approval under rule
7.3, or another specific security
holder approval (specify date of
meeting)
6f
Number of securities issued under
an exception in rule 7.2
6g
If securities issued under rule
7.1A, was issue price at least 75%
of 15 day VWAP as calculated
under rule 7.1A.3? Include the
issue date and both values. Include
the
source
of
the
VWAP
calculation.
6h
If securities were issued under rule
7.1A for non-cash consideration,
state date on which valuation of
consideration was released to ASX
Market Announcements
6i
Calculate the entity’s remaining
issue capacity under rule 7.1 and
rule 7.1A – complete Annexure 1
and
release
to
ASX
Market
Announcements
7
Dates of entering+securities into
uncertificated holdings or despatch
of certificates
8
Number
and
+class
of
all
+securities
quoted
on
ASX
(_including_the securities in section
2 if applicable)
140,725,000 140,725,000
Nil
Nil
Nil
Not applicable
Not applicable
Capacity under LR 7.1 is 16,679,340
Capacity under LR 7.1A is 104,936,227
14 February 2018
Number +Class
1,174,787,269 Ordinary shares
  • See chapter 19 for defined terms.

Appendix 3B Page 2

01/08/2012

Appendix 3B New issue announcement

9
Number
and
+class
of
all
+securities not quoted on ASX
(_including_the securities in section
2 if applicable)
10
Dividend policy (in the case of a
trust, distribution policy) on the
increased capital (interests)
Number +Class
30,000,000
8,122,500
Unlisted Conditional
Performance Options
Unlisted Options
Not applicable

Part 2 - Bonus issue or pro rata issue

11 Is
security
holder
approval
required?
12 Is the issue renounceable or non-
renounceable?
13 Ratio in which the+securities will
be offered
14 +Class of+securities to which the
offer relates
15 +Record
date
to
determine
entitlements
16 Will holdings on different registers
(or subregisters) be aggregated for
calculating entitlements?
17 Policy for deciding entitlements in
relation to fractions
18 Names of countries in which the
entity has+security holders who
will
not
be
sent
new
issue
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19 Closing
date
for
receipt
of
acceptances or renunciations
20 Names of any underwriters
  • See chapter 19 for defined terms.

Appendix 3B Page 3

01/08/2012

Appendix 3B New issue announcement

21 Amount of any underwriting fee or
commission
22 Names of any brokers to the issue
23 Fee or commission payable to the
broker to the issue
24 Amount of any handling fee payable
to brokers who lodge acceptances
or renunciations on behalf of
+security holders
25 If the issue is contingent on
+security holders’ approval, the date
of the meeting
26 Date entitlement and acceptance
form and prospectus or Product
Disclosure Statement will be sent to
persons entitled
27 If the entity has issued options, and
the terms entitle option holders to
participate on exercise, the date on
which notices will be sent to option
holders
28 Date rights trading will begin (if
applicable)
29 Date rights trading will end (if
applicable)
30 How do+security holders sell their
entitlements_in full_through a
broker?
31 How do+security holders sell_part_
of their entitlements through a
broker and accept for the balance?
32 How do+security holders dispose of
their entitlements (except by sale
through a broker)?
33 +Despatch date
  • See chapter 19 for defined terms.

Appendix 3B Page 4

01/08/2012

Appendix 3B New issue announcement

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

  • 34 Type of securities ( tick one )

  • (a)[Securities described in Part 1 ]

  • (b)[All other securities ]

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

  • 35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders

36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over

  • 37 A copy of any trust deed for the additional[+] securities

Entities that have ticked box 34(b)

  • 38 Number of securities for which +quotation is sought

  • 39 Class of +securities for which quotation is sought

  • See chapter 19 for defined terms.

Appendix 3B Page 5

01/08/2012

Appendix 3B New issue announcement

40 Do the[+] securities rank equally in all respects from the date of allotment with an existing[+] class of quoted +securities?

If the additional securities do not rank equally, please state:

  • the date from which they do

  • • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

  • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

41 Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

(if issued upon conversion of another security, clearly identify that other security)

Number +Class

42 Number and[+] class of all[+] securities quoted on ASX ( including the securities in clause 38)

  • See chapter 19 for defined terms.

Appendix 3B Page 6

01/08/2012

Appendix 3B New issue announcement

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted[+] quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before[+] quotation of the[+] securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

==> picture [73 x 67] intentionally omitted <==

Sign here: ........................................................... Date: 15 February 2018 ( ~~Director~~ /Company secretary)

Print name: Jessamyn Lyons

== == == == ==

  • See chapter 19 for defined terms.

Appendix 3B Page 7

01/08/2012

Appendix 3B New issue announcement

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for +eligible entities

Introduced 01/08/12

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

Part 1 Part 1
Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
Insertnumber of fully paid ordinary
securities on issue 12 months before date
of issue or agreement to issue
818,995,965
Addthe following:
• Number of fully paid ordinary securities
issued in that 12 month period under an
exception in rule 7.2
• Number of fully paid ordinary securities
issued in that 12 month period with
shareholder approval
• Number of partly paid ordinary securities
that became fully paid in that 12 month
period
Note:
• Include only ordinary securities here –
other classes of equity securities cannot
be added
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
74,177,576
78,063,728
76,187,500
1,937,500
Nil
Subtractthe number of fully paid ordinary
securities cancelled during that 12 month
period
Nil
“A” 1,049,362,269
  • See chapter 19 for defined terms.

Appendix 3B Page 8

01/08/2012

Appendix 3B New issue announcement

Step 2: Calculate 15% of “A”

Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply“A” by 0.15 157,404,340
Step 3: Calculate “C”, the amount of placement capacity under rule
7.1 that has already been used
Insertnumber of equity securities issued or
agreed to be issued in that 12 month period
140,337,500
_not counting_those issued: 387,500
• Under an exception in rule 7.2
• Under rule 7.1A
• With security holder approval under rule
7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
7.1 that has already been used
Insertnumber of equity securities issued or
agreed to be issued in that 12 month period
140,337,500
_not counting_those issued: 387,500
• Under an exception in rule 7.2
• Under rule 7.1A
• With security holder approval under rule
7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
“C” 140,725,500
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15 157,404,340
Note: number must be same as shown in
Step 2
placement capacity under rule 7.1
“A” x 0.15 157,404,340
Note: number must be same as shown in
Step 2
Subtract“C” 140,725,500
Note: number must be same as shown in
Step 3
Total[“A” x 0.15] – “C” 16,679,340
[Note: this is the remaining placement
capacity under rule 7.1]
  • See chapter 19 for defined terms.

Appendix 3B Page 9

01/08/2012

Appendix 3B New issue announcement

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

“A” 1,049,362,269 Note: number must be same as shown in Step 1 of Part 1

Step 2: Calculate 10% of “A”

“D” 0.10 Note: this value cannot be changed Multiply “A” by 0.10 104,936,227

Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used

Insert number of equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

nil

Notes:

  • This applies to equity securities – not just ordinary securities

  • Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed

  • Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

  • It may be useful to set out issues of securities on different dates as separate line items

“E” nil

  • See chapter 19 for defined terms.

Appendix 3B Page 10

01/08/2012

Appendix 3B New issue announcement

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
“A” x 0.10
Note: number must be same as shown in
Step 2
104,936,227
Subtract“E”
Note: number must be same as shown in
Step 3
nil
Total[“A” x 0.10] – “E” 104,936,227
Note: this is the remaining placement
capacity under rule 7.1A
  • See chapter 19 for defined terms.

Appendix 3B Page 11

01/08/2012

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Ardiden Limited ABN 82 110 884 252

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Bradley Boyle
Date of last notice 10 August 2017

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct Interest
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Date of change 14 February 2018
No. of securities held prior to change Direct:
1. 4,324,678 ordinary shares
2. 5,000,000 Tranche 1 Unlisted 2 cent
Conditional Performance Options
expiring 9 August 2019.
3. 5,000,000 Tranche 2 Unlisted 2 cent
Conditional Performance Options
expiring 9 August 2019.
Class Ordinary Shares & Unlisted Options
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Number acquired 1. 1,000,000 Ordinary Shares
2. 200,000 Unlisted Options
- Exercise price $0.016 cents,
- Expiry 29 November 2018
3. 200,000 Ordinary Shares
Number disposed 200,000 Unlisted options
Value/Consideration
Note: If consideration is non-cash, provide details and estimated valuation
1. $16,000
2. Nil.
3. $3,200
No. of securities held after change Direct:
1. 5,524,678 ordinary shares.
2. 5,000,000 Tranche 1 Unlisted 2 cent
Conditional Performance Options
expiring 9 August 2019.
3. 5,000,000 Tranche 2 Unlisted 2 cent
Conditional Performance Options
expiring 9 August 2019.
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
1. Placement approved by shareholders
at the Company’s General Meeting
held on 13 February 2018.
2. Issue of Unlisted Options attached to
the placement shares above.
3. Conversion of Options

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed Period

Part 3 –+Closed Period
Were the interest in the securities
or
contracts
detailed
above
trading during a+closed period
where prior written clearance
was required?
No
If so, was prior written clearance
provided to allow the trade to
proceed during this period?
N/A
If prior written clearance was
provided, on what date was this
provided?
N/A

Date of Notice: 15 February 2018

  • See chapter 19 for defined terms.

Appendix 3Y Page 3

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Ardiden Limited ABN 82 110 884 252

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Neil Hackett
Date of last notice 10 August 2017

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect Interest
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Corporate Starboard Pty Ltd, a Company Mr
Hackett has a relevant interest in.
Date of change 14 February 2018
No. of securities held prior to change Indirect:
Corporate Starboard Pty Ltd
1. 15,593,178 Ordinary Shares
2. 2,500,000 Tranche 1 Unlisted 4 cent
Conditional Performance Options
expiring 1 July 2019.
3. 2,500,000 Tranche 2 Unlisted 4 cent
Conditional Performance Options
expiring 1 July 2019.
Class Ordinary Shares & Unlisted Options
Number acquired 1. 625,000 Ordinary Shares
2. 125,000 Unlisted Options
-
Exercise price $0.016 cents,
-
Expiry 29 November 2018.
3. 125,000 Ordinary Shares
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Number disposed 125,000 Unlisted Options
Value/Consideration
Note: If consideration is non-cash, provide details and estimated valuation
1. $10,000
2. Nil
3. $2,000
No. of securities held after change Indirect:
Corporate Starboard Pty Ltd
1. 16,343,178 Ordinary Shares
2. 2,500,000 Tranche 1 Unlisted 4 cent
Conditional Performance Options
expiring 1 July 2019.
3. 2,500,000 Tranche 2 Unlisted 4 cent
Conditional Performance Options
expiring 1 July 2019.
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
1. Placement approved by shareholders
at the Company’s General Meeting
held on 13 February 2018.
2. Issue of Unlisted Options attached to
the placement shares above.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
Interest after change
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed Period

Part 3 –+Closed Period
Were the interest in the securities
or
contracts
detailed
above
trading during a+closed period
where prior written clearance
was required?
No
If so, was prior written clearance
provided to allow the trade to
proceed during this period?
N/A
If prior written clearance was
provided, on what date was this
provided?
N/A

Date of Notice: 15 February 2018

  • See chapter 19 for defined terms.

Appendix 3Y Page 3

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Ardiden Limited ABN 82 110 884 252

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Michelle Li
Date of last notice 7 July 2016

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct Interest
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
N/A
Date of change 14 February 2018
No. of securities held prior to change Direct:
Ming Fen Li
1. 2,500,000 Tranche 1 Unlisted 4 cent
Conditional Performance Options
expiring 1 July 2019.
2. 2,500,000 Tranche 2 Unlisted 4 cent
Conditional Performance Options
expiring1July2019.
Class Ordinary Shares & Unlisted Options
Number acquired 1. 312,500 Ordinary Shares.
2. 62,500 Unlisted Options
-
Exercise price $0.016 cents,
-
Expiry 29 November 2018.
Number disposed Nil
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration
Note: If consideration is non-cash, provide details and estimated valuation
$5,000
No. of securities held after change Direct:
Ming Fen Li
1. 312,500 Ordinary Shares.
2. 62,500 Unlisted Options
-
Exercise price $0.016 cents,
-
Expiry 29 November 2018.
3. 2,500,000 Tranche 1 Unlisted 4 cent
Conditional Performance Options
expiring 1 July 2019.
4. 2,500,000 Tranche 2 Unlisted 4 cent
Conditional Performance Options
expiring 1 July 2019.
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
1. Placement approved by shareholders
at the Company’s General Meeting
held on 13 February 2018.
2. Issue of Unlisted Options attached to
the placement shares above.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
Interest after change
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed Period

Part 3 –+Closed Period
Were the interest in the securities
or
contracts
detailed
above
trading during a+closed period
where prior written clearance
was required?
No
If so, was prior written clearance
provided to allow the trade to
proceed during this period?
N/A
If prior written clearance was
provided, on what date was this
provided?
N/A

Date of Notice: 15 February 2018

  • See chapter 19 for defined terms.

Appendix 3Y Page 3

11/3/2002